These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 25351610
1. Comparison of LMWH versus UFH for hemorrhage and hospital mortality in the treatment of acute massive pulmonary thromboembolism after thrombolytic treatment : randomized controlled parallel group study. Ucar EY, Akgun M, Araz O, Tas H, Kerget B, Meral M, Kaynar H, Saglam L. Lung; 2015 Feb; 193(1):121-7. PubMed ID: 25351610 [Abstract] [Full Text] [Related]
2. [Comparison of unfractionated heparin and low molecular weight heparin in pulmonary thromboembolism: meta-analysis]. Zhai ZG, Wang C, Liu YM, Qin ZQ. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):221-6. PubMed ID: 15266820 [Abstract] [Full Text] [Related]
4. Economic and utilization outcomes associated with choice of treatment for venous thromboembolism in hospitalized patients. Knight KK, Wong J, Hauch O, Wygant G, Aguilar D, Ofman JJ. Value Health; 2005 Jun; 8(3):191-200. PubMed ID: 15877591 [Abstract] [Full Text] [Related]
8. Low molecular weight heparin and unfractionated heparin for prevention of thrombo-embolism in general surgery: a meta-analysis of randomised clinical trials. Palmer AJ, Schramm W, Kirchhof B, Bergemann R. Haemostasis; 1997 Jun; 27(2):65-74. PubMed ID: 9212354 [Abstract] [Full Text] [Related]
9. Inverse relationship of bleeding risk with clot burden during pulmonary embolism treatment with LMW heparin. Wang C, Zhai Z, Yang Y, Cheng Z, Ying K, Liang L, Dai H, Huang K, Lu W, Zhang Z, Cheng X, Shen YH, Davidson BL, China National Venous Thromboembolism (VTE) Study Group. Clin Respir J; 2016 Sep; 10(5):596-605. PubMed ID: 25619125 [Abstract] [Full Text] [Related]
10. Acute pulmonary embolism in cancer patients admitted to intensive care unit: Impact of anticoagulant treatment on 90-day mortality and risk factors, results of a multicentre retrospective study. Mokart D, Serre E, Bruneel F, Kouatchet A, Lemiale V, Chow-Chine L, Faucher M, Sannini A, Valade S, Bisbal M, Gonzalez F, Servan L, Darmon M, Azoulay E. Thromb Res; 2024 May; 237():129-137. PubMed ID: 38583310 [Abstract] [Full Text] [Related]
16. Use of unfractionated heparin and a low-molecular-weight heparin following thrombolytic therapy for acute ST-segment elevation myocardial infarction. Wang XK, Zhang Y, Yang CM, Wang Y, Liu GY. Clin Drug Investig; 2006 Oct 06; 26(6):341-9. PubMed ID: 17163268 [Abstract] [Full Text] [Related]
18. Comparative effectiveness of low-molecular-weight heparin versus unfractionated heparin for thromboembolism prophylaxis for medical patients. Rothberg MB, Pekow PS, Lahti M, Lindenauer PK. J Hosp Med; 2012 Oct 06; 7(6):457-63. PubMed ID: 22473716 [Abstract] [Full Text] [Related]
19. Low molecular weight heparin for prevention of microvascular occlusion in digital replantation. Lin PT, Wang SH, Chi CC. Cochrane Database Syst Rev; 2020 Apr 17; 4(4):CD009894. PubMed ID: 32302004 [Abstract] [Full Text] [Related]